- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03901794
Relationship Between Hemodynamic Change and Fluid Removed During Hemodialysis
April 2, 2019 updated by: National Taiwan University Hospital
Relationship Between Hemodynamic Change and Fluid Removed During Hemodialysis Measured by Non-invasive Monitor
Relationship between hemodynamic change and fluid removed during hemodialysis measured by non-invasive monitor
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
By applying non-invasive hemodynamic monitors (ex.
ClearSight, I-COM), the trends of mean arterial pressure (MAP), stroke volume (SV), cardiac index (CI) and calculated systemic vascular resistance (SVR) were collected along with volume removal by hemodialysis on ESRD patients.
All data were compared and analyzed to detect the sequential body volume status as well as the autonomic responses during hemodialysis.
Study Type
Observational
Enrollment (Actual)
60
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Taipei, Taiwan, 100
- National Taiwan University Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
end-stage renal disease patients who were under regular hemodialysis
Description
Inclusion criteria:
1. Patients who were schedured with regular hemodialysis for end-stage renal disease.
Exclusion criteria:
- Emergent hemodialysis
- Medical conditions with poor peripheral circulation such as Raynaud's disease or PAOD
- Skin defects or wounds over area to be applied for measurement (Wrist and fingers)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
With Clear Sight
record and observe the data including SVI, CI, SVR with clearSight during hemodialysis
|
MAP, HR, CO, SVI, from Non-invasive hemodynamic monitor
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
fluid removed along with hemodialysis
Time Frame: 4 hours
|
the fluid volume removed from hemodialysis (mL/hour),
|
4 hours
|
changes of mean arterial pressure along with hemodialysis
Time Frame: 4 hours
|
record of mean arterial pressure (mmHg) per 30 minutes
|
4 hours
|
changes of heart rate along with hemodialysis
Time Frame: 4 hours
|
record of heart rate (beats/ minute) per 30 minutes
|
4 hours
|
changes of stroke volume along with hemodialysis
Time Frame: 4 hours
|
record of stroke volume (SV, (mL/ beat)per 30 minutes
|
4 hours
|
changes of cardiac output along with hemodialysis
Time Frame: 4 hours
|
record of cardiac output ( liter/ minute)per 30 minutes
|
4 hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Chair: ST Chen, National Taiwan University
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 6, 2017
Primary Completion (Actual)
November 23, 2018
Study Completion (Actual)
November 30, 2018
Study Registration Dates
First Submitted
March 11, 2019
First Submitted That Met QC Criteria
April 2, 2019
First Posted (Actual)
April 3, 2019
Study Record Updates
Last Update Posted (Actual)
April 3, 2019
Last Update Submitted That Met QC Criteria
April 2, 2019
Last Verified
April 1, 2017
More Information
Terms related to this study
Other Study ID Numbers
- 201702064RIPB
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
product manufactured in and exported from the U.S.
Yes
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hemodialysis Complication
-
Saint-Joseph UniversityTerminated
-
Fresenius Kabi Taiwan Ltd.Chung Shan Medical UniversityCompleted
-
Eurofarma Laboratorios S.A.Completed
-
Universitaire Ziekenhuizen KU LeuvenNIPROCompletedHemodialysis ComplicationBelgium
-
Carlo Maria GuastoniUnknown
-
nooshin daliliCompletedHemodialysis Complication
-
Assiut UniversityNot yet recruitingHemodialysis Complication
-
RenJi HospitalNot yet recruitingHemodialysis Complication
-
Cairo UniversityCompletedHemodialysis ComplicationEgypt
-
China Medical University HospitalMinistry of Science and Technology, TaiwanActive, not recruiting
Clinical Trials on Non-invasive hemodynamic monitor
-
University of California, Los AngelesEnrolling by invitationPulmonary Arterial Hypertension | Chronic Thromboembolic Pulmonary HypertensionUnited States
-
CareTaker Medical LLCUniversity of Virginia; Yale School of Medicine; Orange County Research CenterCompletedBlood Pressure | Heart Rate Variability | Cardiac Output | Left Ventricular Ejection TimeUnited States
-
University Hospital of North NorwayKnut Helge Kaspersen, MD; Per Ivar Kaaresen, MD, PhD; Nils Thomas Songstad, MD... and other collaboratorsWithdrawn
-
University of California, Los AngelesEnrolling by invitationPulmonary Disease | Pulmonary Embolism | Pulmonary Embolus/Emboli | Pulmonary Embolism and Thrombosis | Pulmonary Embolism Subacute Massive | Pulmonary Embolism Acute MassiveUnited States
-
Cairo UniversityCompletedObesity | Blood PressureEgypt
-
Intelomed, Inc.TerminatedHeart FailureUnited States
-
Indiana UniversityNot yet recruitingHydrocephalus in InfantsUnited States
-
Medical Centre LeeuwardenCompleted
-
GE HealthcareCompletedHealthyUnited States
-
CareTaker Medical LLCUniversity of VirginiaCompletedBlood Pressure